2021 VIRTUAL UTAH CANCER SUMMIT: ADVANCING RESEARCH, INNOVATION, AND POLICY
September 16, 2021
9:00 am
Virtual
Attend this year’s virtual Utah Cancer Summit and hear from Utah life sciences companies on the cutting-edge of cancer research, treatments and potential cures.
David Bearss, PhD, co-director of the Center for Investigational Therapeutics and associate professor at the University of Utah’s Huntsman Cancer Institute and Department of Oncological Sciences and President of Xenter’s therapeutics division will be the Summit’s keynote speaker.
A panel of distinguished experts from IONIQ Sciences, Known Medicine, PEEL Therapeutics and SDP Oncology will present on their work in the cancer field. BioUtah’s President and CEO, Kelvyn Cullimore, will moderate this inspiring discussion.
Recent News
- Biolexis Therapeutics Advances Breakthrough GLP-1 and AMPK Programs into First-in-Human Clinical Trials
- Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
- NUSANO STABLE ISOTOPE PROGRAM ENRICHES GADOLINIUM-160 TO 99.2% PURITY
- CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
